These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 9783260

  • 1. Isolation of synaptotagmin as a receptor for types A and E botulinum neurotoxin and analysis of their comparative binding using a new microtiter plate assay.
    Li L, Singh BR.
    J Nat Toxins; 1998 Oct; 7(3):215-26. PubMed ID: 9783260
    [Abstract] [Full Text] [Related]

  • 2. Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G.
    Rummel A, Karnath T, Henke T, Bigalke H, Binz T.
    J Biol Chem; 2004 Jul 16; 279(29):30865-70. PubMed ID: 15123599
    [Abstract] [Full Text] [Related]

  • 3. The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a.
    Nishiki T, Tokuyama Y, Kamata Y, Nemoto Y, Yoshida A, Sato K, Sekiguchi M, Takahashi M, Kozaki S.
    FEBS Lett; 1996 Jan 15; 378(3):253-7. PubMed ID: 8557112
    [Abstract] [Full Text] [Related]

  • 4. Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins.
    Kozaki S, Kamata Y, Watarai S, Nishiki T, Mochida S.
    Microb Pathog; 1998 Aug 15; 25(2):91-9. PubMed ID: 9712688
    [Abstract] [Full Text] [Related]

  • 5. Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes.
    Nishiki T, Kamata Y, Nemoto Y, Omori A, Ito T, Takahashi M, Kozaki S.
    J Biol Chem; 1994 Apr 08; 269(14):10498-503. PubMed ID: 8144634
    [Abstract] [Full Text] [Related]

  • 6. Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins.
    Peng L, Berntsson RP, Tepp WH, Pitkin RM, Johnson EA, Stenmark P, Dong M.
    J Cell Sci; 2012 Jul 01; 125(Pt 13):3233-42. PubMed ID: 22454523
    [Abstract] [Full Text] [Related]

  • 7. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes.
    Baldwin MR, Barbieri JT.
    Biochemistry; 2007 Mar 20; 46(11):3200-10. PubMed ID: 17311420
    [Abstract] [Full Text] [Related]

  • 8. Location of the synaptosome-binding regions on botulinum neurotoxin B.
    Dolimbek BZ, Steward LE, Aoki KR, Atassi MZ.
    Biochemistry; 2012 Jan 10; 51(1):316-28. PubMed ID: 22146011
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
    Sharma SK, Singh BR.
    Biochemistry; 2004 Apr 27; 43(16):4791-8. PubMed ID: 15096048
    [Abstract] [Full Text] [Related]

  • 11. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor.
    Rummel A, Häfner K, Mahrhold S, Darashchonak N, Holt M, Jahn R, Beermann S, Karnath T, Bigalke H, Binz T.
    J Neurochem; 2009 Sep 27; 110(6):1942-54. PubMed ID: 19650874
    [Abstract] [Full Text] [Related]

  • 12. Characterization of Clostridium botulinum type B neurotoxin associated with infant botulism in japan.
    Kozaki S, Kamata Y, Nishiki T, Kakinuma H, Maruyama H, Takahashi H, Karasawa T, Yamakawa K, Nakamura S.
    Infect Immun; 1998 Oct 27; 66(10):4811-6. PubMed ID: 9746583
    [Abstract] [Full Text] [Related]

  • 13. Cloning, high-level expression, single-step purification, and binding activity of His6-tagged recombinant type B botulinum neurotoxin heavy chain transmembrane and binding domain.
    Zhou Y, Singh BR.
    Protein Expr Purif; 2004 Mar 27; 34(1):8-16. PubMed ID: 14766296
    [Abstract] [Full Text] [Related]

  • 14. Hemagglutinin-33 of type A botulinum neurotoxin complex binds with synaptotagmin II.
    Zhou Y, Foss S, Lindo P, Sarkar H, Singh BR.
    FEBS J; 2005 Jun 27; 272(11):2717-26. PubMed ID: 15943806
    [Abstract] [Full Text] [Related]

  • 15. Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity.
    Rummel A.
    Curr Top Microbiol Immunol; 2013 Jun 27; 364():61-90. PubMed ID: 23239349
    [Abstract] [Full Text] [Related]

  • 16. Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin.
    Weisemann J, Stern D, Mahrhold S, Dorner BG, Rummel A.
    Toxins (Basel); 2016 May 17; 8(5):. PubMed ID: 27196927
    [Abstract] [Full Text] [Related]

  • 17. Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity.
    Jin R, Rummel A, Binz T, Brunger AT.
    Nature; 2006 Dec 21; 444(7122):1092-5. PubMed ID: 17167421
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Gangliosides interact with synaptotagmin to form the high-affinity receptor complex for botulinum neurotoxin B.
    Flores A, Ramirez-Franco J, Desplantes R, Debreux K, Ferracci G, Wernert F, Blanchard MP, Maulet Y, Youssouf F, Sangiardi M, Iborra C, Popoff MR, Seagar M, Fantini J, Lévêque C, El Far O.
    Proc Natl Acad Sci U S A; 2019 Sep 03; 116(36):18098-18108. PubMed ID: 31431523
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.